Blog > Featuring... > Take 26% gains on Indian pharma giant Dr. Reddy’s (RDY)
Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

Take 26% gains on Indian pharma giant Dr. Reddy’s (RDY)

Today's Financial News - Posted September 25, 2009

Photo 108It’s a rainy day and the markets are all but inspiring. So take gains on Dr. Reddy’s Laboratories Limited (NYSE:RDY) and buy yourself a cuppa cheer!

by J. Christoph Amberger

Baltimore, MD — TFN: Don’t tell me we’re not doing anything for readers of of free service, the TFN eNews, and visitors of our TFN home page.

On August 20, we posted a free TFN Special Report, The Top Swine Flu Vaccine Stocks under $20, in which we recommended three stocks.

One of them, Sinovac (AMEX:SVA), gave us 30% gains on Aug. 28.

Today, the arguably largest and slowest-moving of the pig flu trip stepped on the gas. On Aug. 20, I recommended you “buy Dr. Reddy’s Laboratories Limited (NYSE:RDY) under $16.50 for possible gains of 10-15% throughout 2010.”

Today, our Indian generics wallah is trading at $20.43. In our TFN tracking portfolio, this clocks in as a 25.95% gain.

I say we take it!

Now, this one’s one us. We won’t add this to the 63 double-digit gainers we have produced for members of our premium servce Hot Stock Confidential so far this year. If you took our advice and are not an HSC member yet, I recommend you take some of your gains… and re-invest them into a 3-month trial subscription to HSC!


Next Article: Q4 Update: TFN Complete Guide to Stem Cell Stocks under $10

Related Articles

Posted by J. Christoph Amberger · Filed Under Featuring..., International Investing 

Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

 Add to Technorati Favorites | Follow Us on Twitter!

Be the first to leave a reply.

Your comments are welcome